SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 81325990212

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81325990212 and manufactured by ACRO BIOTECH, INC. (MONTCLAIR). The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until Jan 09, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81325990212
2 Related Devices
Registration Details
ANVISA Registration Number: 81325990212
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família Teste rápido de antígeno Covid-19 (Saliva) para autoteste
Risk Class III

Registration Details

81325990212

25351318792202231

19933144000129

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jan 09, 2023

09/01/2033

09/18/2025 19:00:01

Família Teste rápido de antígeno Covid-19 (Saliva) para autoteste
Risk Class III

Registration Details

81325990212

25351318792202231

19933144000129

Dates and Status

Jan 09, 2023

09/01/2033

09/18/2025 19:00:01